KANK2 and cancer: KANK2 demonstrates strong diagnostic potential across various cancers, with an area under the curve (AUC) greater than 0.75 in 13 cancer types, including BLCA (AUC = 0.867), BRCA (AUC = 0.844), CESC (AUC = 0.993), CHOL (AUC = 0.997), COAD (AUC = 0.830), KICH (AUC = 0.918), KIRP (AUC = 0.775), LIHC (AUC = 0.794), LUAD (AUC = 0.960), PRAD (AUC = 0.819), READ (AUC = 0.885), UCEC (AUC = 0.907), and SKCM (AUC = 0.864).